tiprankstipranks
Trending News
More News >
Crispr Therapeutics AG (CRSP)
NASDAQ:CRSP
US Market

Crispr Therapeutics AG (CRSP) Technical Analysis

Compare
10,823 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
4Neutral
13Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Crispr Therapeutics AG’s (CRSP) Moving Averages Convergence Divergence (MACD) indicator is -1.86, suggesting Crispr Therapeutics AG is a Buy.
Crispr Therapeutics AG’s (CRSP) 20-Day exponential moving average is 51.59, while Crispr Therapeutics AG’s (CRSP) share price is $48.32, making it a Sell.
Crispr Therapeutics AG’s (CRSP) 50-Day exponential moving average is 53.91, while Crispr Therapeutics AG’s (CRSP) share price is $48.32, making it a Sell.

Crispr Therapeutics AG (CRSP) Pivot Points

Feb 14, 2026, 12:22 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
46.20
47.44
48.14
49.38
50.08
51.32
52.02
Fibonacci
47.44
48.18
48.64
49.38
50.12
50.58
51.32
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Crispr Therapeutics AG (CRSP) Moving Averages

Feb 14, 2026, 12:22 AM
Period
Simple
Exponential
MA5
48.29Buy
48.94Sell
MA10
49.83Sell
49.98Sell
MA20
52.46Sell
51.59Sell
MA50
54.42Sell
53.91Sell
MA100
58.26Sell
54.98Sell
MA200
53.76Sell
51.87Sell
Crispr Therapeutics AG’s (CRSP) 10-Day exponential moving average is 49.98, while Crispr Therapeutics AG’s (CRSP) share price is $48.32, making it a Sell.
Crispr Therapeutics AG’s (CRSP) 100-Day exponential moving average is 54.98, while Crispr Therapeutics AG’s (CRSP) share price is $48.32, making it a Sell.
Crispr Therapeutics AG’s (CRSP) stock price is $48.32 and Crispr Therapeutics AG’s (CRSP) 50-day simple moving average is 54.42, creating a Sell signal.
Crispr Therapeutics AG’s (CRSP) stock price is $48.32 and Crispr Therapeutics AG’s (CRSP) 100-day simple moving average is 58.26, creating a Sell signal.
Crispr Therapeutics AG’s (CRSP) stock price is $48.32 and Crispr Therapeutics AG’s (CRSP) 200-day simple moving average is 53.76, creating a Sell signal.

Crispr Therapeutics AG (CRSP) Technical Indicators

Feb 14, 2026, 12:22 AM
Name
Value
Implied Action
RSI (14)
40.78
Neutral
STOCH (9,6)
39.32
Neutral
STOCHRSI (14)
22.37
Neutral
MACD (12,26)
-1.86
Buy
ADX (14)
13.91
Buy
Williams %R
-81.61
Buy
CCI (14)
-110.47
Buy
ATR (14)
2.95
-
Ultimate Oscillator
46.01
Neutral
ROC
-20.54
Sell
Crispr Therapeutics AG’s (CRSP) Relative Strength Index (RSI) is 40.78, creating a Neutral signal.
Crispr Therapeutics AG’s (CRSP) Trend Strength Indicator (ADX) is 13.91, creating a Buy signal.
Crispr Therapeutics AG’s (CRSP) Commodity Channel Index (CCI) is -110.47, creating a Buy signal.
Crispr Therapeutics AG’s (CRSP) Price Rate of Change (ROC) is -20.54, creating a Sell signal.

FAQ

Is CRSP a Buy, Hold, or Sell?
Based on CRSP’s technical indicators, CRSP is a Sell.
    What is CRSP’s RSI (14)?
    CRSP’s RSI (14) is 40.78, which suggests CRSP is a Neutral.
      What is CRSP’s MACD?
      CRSP’s MACD is -1.86, which suggests CRSP is a Buy.
        What is CRSP’s 5-day moving average?
        CRSP’s 5-day moving average is 48.29, which suggests CRSP is a Buy.
          What is CRSP’s 20-day moving average?
          CRSP 20-day moving average is 52.46, which suggests CRSP is a Sell.
            What is CRSP’s 50-day moving average?
            CRSP’s 50-day moving average is 54.42, which suggests CRSP is a Sell.
              What is CRSP’s 200-day moving average?
              CRSP’s 200-day moving average is 53.76, which suggests CRSP is a Sell.
                What is CRSP’s Williams % R (14)?
                CRSP’s Williams % R (14) is -81.61, which suggests CRSP is a Buy.
                  What is CRSP’s CCI (14)?
                  CRSP’s CCI (14) is -110.47, which suggests CRSP is a Buy.